Gian Luigi Lenzi (GLL): As Chair of the MDS-European Section, can you illustrate the role you would like the EAN to cover within the world of European Neurology? Olivier Rascol (OR): In my view, the EAN has crucial strategic and practical roles to cover in order to reinforce the knowledge of neurological disorders and improve the care of neurological patients in Europe and worldwide.

Gian Luigi Lenzi (GLL): Can you briefly describe the Alliance for Biomedical Research in Europe (Biomed Alliance). Gustave Moonen (GM): The Alliance for biomedical research in Europe (Biomed Alliance) is a non-profit organisation founded in 2010 by four societies namely the European Cancer Organisation (ECCO), the European Respiratory Society (ERS), the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD).

by Vitalie Lisnic   Neuromuscular diseases have traditionally been overlooked, underdiagnosed and poorly treated when compared with other neurological diseases. However, neuromuscular disorders are diverse and extremely common, possibly accounting for up to 40% of neurological diagnoses.
Neuromuscular disorders are… Continue Reading

Following a “golden century” that had started with Moritz Heinrich Romberg in 1832 (see the previous chapters of this series) German neurology entered its dark age in 1933. Legislation implemented by the “Nazi“ party banned many Jewish fellow citizens including physicians from their professions and from using their possessions.

by Deliy Lenzi Almost 150 years ago Carl Wernicke first described a vertical large flat bundle of nerve fibres connecting sub-regions of the visual system. It appeared again in the 1918 edition of Gray’s Anatomy, but eventually fell into obscurity… Continue Reading

The first paper that I would like to point out to Neuropenews readers has attracted my attention because it concerns a very general therapeutical and social problem, that is the costs of drugs, and the choice between a “brand” drug and its “generic” counterpart. It is a “perspective” paper, published on the 13 November issue of the New England J of Medicine, by Jonathan D. Alpers, William M. Stauffer & Aaron S. Kesselheim ( NEJM, 2014; 371;1859-1862) : “High-Cost Generic Drugs – Implications for Patients and Policymakers”. This paper refers mainly to USA and FDA problems and initiatives. However, I feel deeply in my gut that these problems will pretty soon affect European countries too.

Neurological diseases are seriously affecting life quality of the patients. Many of these diseases are followed by life-long disabilities or the patients even need care for the rest of their lives. Our daily work for the patients with neurological diseases transfers for politicians into costs for the Society and a recent analysis has found the annual costs for neurological diseases in Europe to be >300.000 Mio €¹, which is more than the annual budget of the German government.

All e-learning activities are free-of-charge for EAN members registered to www.eaneurology.org! Answer all questions correctly and you will receive one hour of CME. European Journal of Neurology
Every month one article is chosen for online learning. The following articles are… Continue Reading

In 2015, up to 5 scientific and up to 3 educational fellowships will be offered to support young European neurologists to carry out research projects in clinical and basic neurology. The objective is to support young and active neurologists wishing… Continue Reading

Please register early for the Teaching and Hands-on Courses via the Congress Website. There are still tickets available. As in previous years, printed manuscripts as well as a CD-Rom with the manuscripts of all Teaching and Hands-on Courses can be… Continue Reading

Report from Dr Khristina Derevyanko from Russia visiting the Danish Headache Center, Glostrup Hospital, Denmark under the supervision of Dr Jes Olesen.

The Department of Neurology, Divison of Neurology, University Medical Centre Ljubljana, Slovenia, requires a Consultant Neurologist experienced in the field of Movement Disorders and DBS. Applications should be sent to: Ms. Anka Žekš, Department of Neurology, Divison of Neurology, University… Continue Reading

Dear colleagues, On behalf of the European Academy of Neurology and the European Alzheimer’s disease consortium (EADC), we would like to invite all members to express their opinion regarding the use of Mild Cognitive Impairment (MCI) in current European practice… Continue Reading

Here is the link to the latest issue:
http://onlinelibrary.wiley.com/doi/10.1111/ene.2014.21.issue-12/issuetoc?campaign=woletoc Don’t forget: All members of the EAN have free online access to the journal via www.eaneurology.org. If you need help with logging in, please contact headoffice@eaneurology.org European Journal of Neurology –… Continue Reading

The Nobel Prize in physiology and medicine for 2014 has been awarded to three neuroscientists; John O’Keefe, May-Britt Moser and Edvard I. Moser.  They have received the prize for their discoveries of cells that constitute a positioning system in the brain. May-Britt and Edvard Moser is a young, married couple from Trondheim, Norway, that during the last decade has published a series of Science and Nature papers on the grid cells in the entorhinal cortex of the brain. They show how the brain creates a map of the space surrounding us and how we can navigate through a complex environment by using these cells.